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Understanding how the immune system decides between tolerance and activation by antigens
requiresaddressingcytokineregulationasahighlydynamicprocess.Wequantiﬁedthedynamicsof
interleukin-2 (IL-2) signaling in a population of Tcells during an immune response by combining
in silico modeling and single-cell measurements in vitro. We demonstrate that IL-2 receptor
expressionlevelsvarywidelyamongTcells creating a largevariability intheabilityoftheindividual
cells to consume, produce and participate in IL-2 signaling within the population. Our model reveals
that at the population level, these heterogeneous cells are engaged in a tug-of-war for IL-2 between
regulatory (Treg) and effector (Teff) Tcells, whereby access to IL-2 can either increase the survival of
Teff cells or the suppressive capacity of Treg cells. This tug-of-war is the mechanism enforcing, at the
systems level, a core function of Treg cells, namely the speciﬁc suppression of survival signals for
weakly activated Teff cells but not for strongly activated cells. Our integrated model yields
quantitative, experimentally validated predictions for the manipulation of Treg suppression.
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Introduction
In the immune system, T-cell activation critically enforces
self-/non-self-discrimination (Daviset al, 1998). On short time
scales (second to minutes), individual T cells make discrimi-
natory decisions between foreign antigens (that should trigger
an immune response) and self-antigens (that should be
tolerated) (Irvine et al, 2002; Altan-Bonnet and Germain,
2005). However, this ligand discrimination is not always
accurate (Feinerman et al, 2008). As misguided activation
against self-antigens can potentially trigger autoimmune
disorders, mechanisms that correct spurious activation of
individual cells on longer time scales, such as hours or days,
are likely to exist. These longer time scales provide ample
opportunity for cell-to-cell communication. Thus, signaling
between individual cells might have a critical function in
converting unreliable self-/non-self-discriminatory decisions
by individual Tcells into an accurate cell-population decision
to mount or suppress an immune response.
In such balance between immune tolerance versus immune
responsiveness to antigens, it has been proposed that
regulatory Tcells (Treg cells) suppress the onset and develop-
ment of autoimmune diseases (Sakaguchi et al, 1995;
Sakaguchi, 2004) by inhibiting the proliferative clonal expan-
sion of self-antigen-activated effector Tcells (Teff cells) (Chen
et al, 1996; Stephens et al, 2005). By comparison, during a
pathogenic infection, Treg surveillance must be overcome to
allow Teff cells to proliferate and mount a full-scale response
(Pasare and Medzhitov, 2003). Therefore, rather than indis-
criminatingly suppressing all activated T cells (Belkaid et al,
2002), Treg cells display large plasticity in their suppressive
capacities (Sakaguchi, 2004; Lund et al, 2008). They recognize
and speciﬁcally suppress only T cells that could trigger
autoimmune disorders (Stephens et al, 2005). Experimentally,
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(ThorntonandShevach,1998),orwhenT-cellantigenreceptor
(TCR)activationandcostimulatorysignalsare‘strong’enough
(George et al, 2003; Sojka et al, 2005; Tran et al, 2009), Treg
suppression of Teff proliferation can be overcome in vitro.
Proposed mechanisms of suppression by Treg cells remain to
this day diverse and controversial. Recent studies focused on
theroleofinterleukin-2 (IL-2)consumption indeterminingthe
functionofTregcellsandtheircontrolofautoimmunedisorders
(Barthlott et al, 2005; Pandiyan et al, 2007; Busse et al, 2010).
IL-2 was originally characterized as a TCR-inducible, T-cell-
derived and speciﬁc lymphocytotrophic growth hormone that
acts as a positive feedback by promoting T-cell proliferation
and limiting apoptosis during responses against pathogens
(Smith,1984).Reciprocally,IL-2consumptionbyTregcellswas
shown to induce cytokine deprivation and apoptosis of Teff
cells in vitro and to limit inﬂammatory bowel disorder in vivo
(Pandiyan et al, 2007). A quantitative model for the competi-
tion for IL-2 as a critical mechanism to establish the
suppression of Teff cells by Treg cells was recently introduced
(Busse et al, 2010). This model attempted to account for the
complexity of IL-2/IL-2R interactions, physiology and meta-
bolism within a mixed population of Teff and Treg cells. To
account for Treg suppression, this model relies on bistablity of
IL-2 expression, which arises from a positive feedback of IL-2
on its own production. However, this postulate stands in
disagreement with previous experimental observations
(Kim et al, 2006; Villarino et al, 2007), which indicate that
IL-2 feeds back negatively on its own expression, thereby
rigidly curtailing long-term availability of IL-2. Below, we
present further experimental measurements that challenge
somequantitativeandqualitativeaspectsofBusseetal’sstudy
and warrant an alternative model for the IL-2 competition
between Teff and Treg cells to be developed.
Critical parameters that dictate in vitro Teff cell cycle
progression after antigen activation were characterized early as
the IL-2 concentration, the density of IL-2R and the kinetics of
the IL-2/IL-2R interaction (Cantrell and Smith, 1984; Smith and
Cantrell, 1985). There are in fact two classes of IL-2 receptors on
Tcells, one with a relative low afﬁnity (Kd¼10 nM), and another
with 1000-fold higher afﬁnity (Kd¼1 0p M ) .T h e s et w oc l a s s e so f
IL-2-binding sites are created by three non-covalently linked
IL-2R chains. The IL-2Ra chains account for low-afﬁnity IL-2
binding, whereas a heterotrimer of IL-2Ra,I L - 2 R b, and IL-2Rg
accounts for high-afﬁnity IL-2 binding (Wang and Smith, 1987).
The role of the low-afﬁnity receptor has been analyzed
theoretically speciﬁcally in the establishment of an autocrine
loop (Forsten and Lauffenburger, 1994).
The metabolism of the IL-2/IL-2R complex also has a
function in contributing to the complexity of the ligand/re-
ceptor system. Upon binding IL-2, the high-afﬁnity hetero-
trimeric IL-2Rundergoes anacceleratedinternalization, with a
half-time of 15min, whereas IL-2 bound to isolated IL-2Ra
chains is not internalized appreciably (Duprez and Dautry-
Varsat, 1986). IL-2 also regulates itself in at least two ways: by
regulating the expression of its ownreceptor, byenhancing the
expression of IL-2Ra chains, by accelerating IL-2-dependent
internalization and degradation of IL-2R, and also by promot-
ing clonal deletion (Lenardo, 1991). However, subsequent
studieswithIL-2genedeletedmice(Schorleetal,1991)andIL-
2R gene deleted mice (Suzuki et al, 1995; Willerford et al,
1995) demonstrated that, by maintaining the population of
Treg cells, IL-2 also contributes to a negative feedback signal
that limits self-responsiveness and abrogates T-cell-mediated
tissue-speciﬁc autoimmune disorders (Horak et al, 1995).
In this study, we introduce a quantitative model for the
regulation of immune responses by IL-2, in particular the
competition for IL-2 between Teff and Treg cells. Our goal is to
quantify the net effect of IL-2 on a population of Tcells at the
systems level. Accordingly, we constructed a quantitative
model that relies on known factors that determine IL-2
secretion and IL-2 receptor (IL-2R) up/downregulation in both
Teff and Treg cells (Figure 1)—quantitative details are in the
Supplementary information 1. We use a combination of
computational modeling, with in vitro single-cell analysis
and quantiﬁcation of surface and intracellular molecules—
originally introduced to quantify the variability of T-cell
response to antigens (Feinerman et al, 2008)—in order to
dissect the intricacies of IL-2/IL-2R physiology. We demon-
strate how Treg cells differentially suppress weakly activated
but not strongly activated Teff cells. Our quantitative model
highlights a previously unrecognized plasticity in IL-2 regulation
Figure 1 Qualitative model for the regulation of T-cell proliferation by IL-2. Upon antigenic activation, Teff cells secrete IL-2 and upregulate IL-2Ra. The trimeric IL-2R
binds IL-2 to induce phosphorylation of STAT5, promote cell survival, and further upregulate IL-2Ra production while downregulating IL-2 expression. Bound IL-2 is
endocytosedanddegraded.TregcellsneverexpressIL-2butrespondtoitsimilarlyastheyexpressIL-2Raevenwhenlackingantigenicstimulation.IL-2depletionbyTreg
cells constitutes a negative feedback on Teff survival. For details see Supplementary information 1.
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at the system’s level: enforcing self-/non-self-discrimination in
the immune system.
Results
Heterogeneity in IL-2Ra levels drives variable
responsiveness to IL-2 in Teff and Treg cells
To understand quantitatively how individual Tcells respond to
IL-2,weexperimentallymeasuredandmodeledIL-2bindingto
the IL-2R and the subsequent phosphorylation response of
STAT5 (Lin and Leonard, 2000) in individual cells.
We found that fully activated T cells express a 50–100-fold
excess of IL-2Ra chains (CD25) versus (IL-2Rb and IL-2Rg)
chains (CD122 and CD132), see Supplementary information 2
for the validation of these measurements. Moreover, the
variation in expression levels of the IL-2R subunits within a
clonal population is substantial; IL-2Ra levels/cell may span
over three orders of magnitude, variation in IL-2Rb also exists
but is less marked (Figure 2A). Therefore, we aimed to
quantifyhowthedensityofIL-2Rsubunitpercellmaytunethe
sensitivity of a cell’s response to IL-2. Extending the
methodology we previously introduced (Feinerman et al,
2008), we took advantage of the natural variation in the
expression levels of IL-2Ra and IL-2Rb in pre-activated Tcells
to experimentally determine their effects on the capacity to
bind IL-2 and trigger phosphorylation of STAT5 following
10min of exposure to different concentrations of IL-2 (for a
validation of these pSTAT5 measurements by FACS, see
Supplementary information 3).
We constructed separate dose-response curves for subpo-
pulations with given IL-2R subunit levels (Figure 2C; Supple-
mentary information 4). These curves can be parameterized
according to the pSTAT5 amplitude, the pSTAT5 plateau
attained upon exposure to saturating doses of IL-2, and the
EC50, the IL-2 concentration resulting in 50% of the amplitude
inpSTAT5(Figure2D).InFigure2E,wepresenttheamplitudes
and EC50s of these dose-response curves plotted as a function
of the experimentally determined number of IL-2Ra and IL-
2Rb molecules/cell. Our single-cell resolution demonstrates
how the IL-2 EC50 for the phosphorylation of STAT5 is not
constant, but varies 1000-fold, between 100fM and 100pM,
depending on IL-2Ra levels on the cell surface. In particular,
when the IL-2a chain density is very high (410
5/cell), IL-2
binding is very efﬁcient and even subPicomolar concentra-
tions of IL-2 elicit a pSTAT5 response. By comparison, the
amplitude of the pSTAT5 response depends strongly on IL-2Rb
levels, with the amount of activated STAT5 varying 1000-fold.
Moreover, these results are valid for both Treg and Teff cells
(Supplementary information 5).
The formation of a stable ligand/receptor complex triggers
STAT5 phosphorylation (Lin and Leonard, 2000). Using
intracellular staining of T cells exposed to the chimeric
IL-2-Fc for 60min, we established experimentally a simple
relationship between the amount of bound and internalized
IL-2 and the amount of generated pSTAT5 (Figure 2F). Next,
we constructed a simple mathematical model (see Materials
and methods section) for the signaling response to IL-2
in individual cells. The model (Figure 2G) consists of two
reactions for transducing the IL-2 signal from the extracellular
to the intracellular side. The ﬁrst reaction accounts for the
rapid, low-afﬁnity binding of IL-2 to IL-2Ra, whereas the
second interaction involves the association of the IL-2Ra/IL-2
complex with IL-2Rb and IL-2Rg. We found that a more
complicated three-stepmodel inwhichIL-2Rb andIL-2Rgbind
independently in time-separated steps does not ﬁt the data
better than our two-step model (Supplementary information
6). This is also consistent with recently-published FRET
measurements (Pillet et al, 2010). Based on the results from
Figure 2F, we set the number of pSTAT5 proportional to the
number of IL-2/IL-2R complexes formed after 10min of
simulated interaction. Our model correctly reproduces our
experimentalﬁndings that thepSTAT5 EC50and amplitude can
be independently varied by changing the amount of the
different IL-2R chains on the cell surface (Figure 2D, theory).
Note that the Hill coefﬁcient for these IL-2 dose response was
keptto1,assharperdoseresponseswithhigherHillcoefﬁcient
did not ﬁt our experimental data. The afﬁnity of the IL-2Ra
chain for IL-2 is ﬁxed, but by employing two reactions for
activating the IL-2 receptor complex, T cells are capable of
regulating their sensitivity to this growth factor from 100fM
to 1nM. Note that this behavior is not reproducible with
a classical model for IL-2/IL-2R interaction, which consi-
ders only one single IL-2/IL-2R-binding event and uses a
single-afﬁnity constant of 10pM. Hence, our single-cell
measurements unraveled an extreme plasticity in the T cells’
responsiveness to IL-2, which directly depends on the IL-2Ra
expression levels. In the following section, we show that the
expression levels of IL-2Ra in individual cells determine
quantitatively their response to IL-2. Taken together with the
ﬁndings of this section, this will prove to have a pivotal
function in shaping the immune response of a population of
Tcells.
Regulation of IL-2Ra and its functional effects
on Teff or Treg cells
In addition to both IL-2Rb and IL-2Rg,T reg cells constitutively
express IL-2Ra with a geometrical mean of 10
4 molecules/cell
(Supplementary information 2). Hence, theyare constitutively
responsive to IL-2. Furthermore, the IL-2Ra gene promoter
includes pSTAT5 response elements, so that IL-2Ra expression
is regulated by IL-2 in addition to antigen stimulation
(Kim et al, 2006). Accordingly, we measured experimentally
theIL-2Raregulation onCD4
þFoxp3
þ Tregcellsinresponse to
different doses of IL-2 in vitro. We found that Treg cells
upregulate IL-2Ra (Figure 3A), but not IL-2Rb (Figure 3B) in
o24h of exposure to extremely low doses of IL-2 (o100fM;
Figure3A–C). This receptorsubunit upregulation constitutes a
positive feedback mechanism that drives further STAT5
phosphorylation and further IL-2Ra upregulation ultimately
resulting in a higher capacity to bind IL-2. Treg cells exposed to
high concentrations of IL-2 show a decrease in IL-2Rb levels
(Figure 3C), this is due to increased rates of IL-2R endocytosis
and degradation upon IL-2 binding.
Having identiﬁed this positive feedback link between IL-2
and IL-2Ra upregulation, we next quantiﬁed how IL-2R levels
on Treg cells control their efﬁciency for binding, metabolizing
IL-2 tug-of-war between effector and regulatory Tcells
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& 2010 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2010 3Figure 2 Responsiveness to IL-2 depends on the levels of IL-2Ra and IL-2Rb on individual cells. (A, B) T-cell blasts, 65h after antigen stimulation, present highly
variedlevelsofIL-2RaandIL-2Rbontheir surface.Thesmallboxesin(B)representindividualbinswithinthedistributionofIL-2RaandIL-2Rb,foreachweanalyzethe
pSTAT5 response. (C). This heterogeneous population of T-cell blasts was exposed to varied concentrations of IL-2 for 10min, ﬁxed, permeabilized, and stained for
pSTAT5. Measurements were normalized bin by bin by substracting the baseline pSTAT5 level as measured in the corresponding bin of the ‘no IL-2’ condition. Dose
responses are presented for varying levels of IL-2Ra (left panel) or varying levels of IL-2Rb (right panel), as deﬁned by color code in panel (B). (D)A typical sigmoidal ﬁt
for STAT5 phosphorylation that yields Amplitude and EC50 for the IL-2 response. (E) Dose responses for pSTAT5 were analyzed for different expression levels of IL-2
receptor subunits (IL-2Ra and IL-2Rb) in individual cells by FACS (experiment) or modeled (theory, as described in F). Amplitudes are presented in the left panels
(arbitrary units for experiment or number of pSTAT5 for the theory) and EC50 (pM) in the right panels. (F) Costaining for phospho-STAT5 and IL-2-Fc in individual cells
reveals a near linear relationship between IL-2 binding and STAT5 phosphorylation. (G). A biochemical model relates known thermodynamic quantities to whole-cell
pSTAT5 responses to IL-2. In our model, IL-2Rb and IL-2Rg bind to the weakly engaged IL-2Ra all at once: we simulated these chains as a single complex IL-2Rb/
IL-2Rg (Lenardo, 1991).
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ment, as this correlates with their suppressive functionality
(Barthlott et al, 2005; Pandiyan et al, 2007). Figure 2D shows
how sensitivity to IL-2, as measured by the pSTAT5 amplitude,
directly correlates with the capacity to bind IL-2 into a stable
IL-2/IL-2R complex. As IL-2 is rapidly internalized and
degraded once bound to the full IL-2R complex (Smith and
Cantrell, 1985; Hemar et al, 1995), the direct relationship
between IL-2 binding, pSTAT5 response, and IL-2 depletionled
us to hypothesize that Treg cells’ capacity to scavenge IL-2
could vary greatly according to their IL-2Ra levels.
To quantify rates of IL-2 depletion by Treg cells
(a straightforward measurement, as these cells do not produce
IL-2), we compared the IL-2 concentrations over time in four
cultures differing in both the density of the Treg cells as well as
in the initial IL-2Ra levels, obtained by pre-exposure to IL-2
(see the Materials and methods section). When exposed to
4pM of extracellular IL-2, Treg cells whose IL-2Ra levels are
upregulatedbyafactorof2.7(geometricalmean)depletedthis
cytokine 1.6±0.3 times faster than those with basal IL-2Ra
levels. Practically, this fasterdepletion can decrease IL-2 levels
below functional signiﬁcance (0.1pmol) after 24h, while
slowerdepletionmayleaveenoughIL-2(41pmol)forpSTAT5
response (Figure 3D). This enhanced rate of IL-2 depletion is
quantitatively explained by our biochemical model that takes
into account concomitant IL-2Ra upregulation and IL-2
endocytosis (ﬁts in Figure 3D). These measurements, along
with a 10-min depletion assay presented in Supplementary
information 7, validated our computer model (Figure 2E)
quantifying thevariableabilityof Tregcells to deplete IL-2 from
the extracellular environment. Note that Treg cells that
have been pre-exposed to IL-2, ensuing upregulation of their
IL-2Ra levels, become more efﬁcient at IL-2 depletion. Hence,
wehave quantiﬁed how Tregcells depleteIL-2 signiﬁcantlyand
dynamically in vitro.
In Teff cells, IL-2Ra expression is inducible and regulated by
several transcription factorsactivated by both antigen stimula-
tion and cytokine signals (Kim et al, 2006). We found that
IL-2Ra levels on the fraction of Teff cells that are activated and
express IL-2Ra correlate with agonist peptide concentration
(Figure 3E). When TCR activation is suboptimal due to low
antigen concentrations, IL-2 enhances the upregulation of
IL-2Ra levels in the activated population. By comparison, when
TCR activation is strong due to a higher-antigen concentration,
IL-2 is not required to induce high densities of IL-2Ra on Teff
cells (Figure 3E). Using these results, together with insights
from Figure 2, we could establish a causal link between strong
TCR stimulation, high IL-2Ra levels and elevated sensitivity to
IL-2, that would lead to enhanced STAT5 phosphorylation, and
thereby decreased cell death (Ihle, 2001).
Variability of IL-2Ra upregulation in cocultures
of Teff and Treg cells
So far, our ﬁndings have shown that both Teff and Treg cells are
able to upregulate their sensitivity to IL-2 when being exposed
to this very cytokine. To investigate whether this has the
potential to affect the behavior of a population of Tcells, we
next tested whether the IL-2 that Teff cells secrete upon
Figure 3 Dynamics of IL-2Ra upregulation and IL-2 depletion for Treg and Teff cells. IL-2Ra (A) and IL-2Rb (B) levels on isolated Treg cells incubated in the presence
of 10fM to 1pM IL-2 for 40h. Results are summarized in (C), revealing that Treg cells upregulate IL-2Ra by six-fold with an EC50 of 60fM of IL-2. Similar results were
obtained for non-isolated Treg cells. (D) Depletion of IL-2 in vitro in four different conditions of Treg number and IL-2Ra levels. IL-2Ra levels on Treg cells that were pre-
exposedtoIL-2(CD25
hi)areinitiallycenteredaround2.7 10
4molecules/cell,whichis2.7timeshigherthanthelevelsofthisreceptoroncellsderivedfromPBS-treated
mice(CD25
lo). Thefourdepletion curves were ﬁttedatoncebyadjustinga singleparameter(Po0.05). (E)IL-2Raexpression levelsamong activatedTeffcellsincrease
with peptide stimulation (38h). Saturating levels of IL-2 does not restore full IL-2Ra upregulation for cells stimulated with low-antigen concentrations. Blocking IL-2
decreases IL-2Ra levels for intermediate peptide stimulation. Error bars for Figure 3C and E are smaller than the graph symbols.
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neighboring Treg cells. We cocultured Treg cells (sorted as an
endogenous cohort of CD4
þCD25
þ cells within a population
of B10.A splenocytes), and naive T cells from 5C.C7 TCR-
transgenic mice that become Teff cells upon activation with the
peptide antigen K5 presented by B10.A splenocytes (Krogs-
gaard et al, 2003). In our assay, most polyclonal Treg cells are
not TCR activated by this speciﬁc antigen. We found that after
27h, the IL-2 produced by peptide-activated Teff cells indeed
induced 10-fold upregulation of IL-2Ra on Treg cells
(Figure 4A), and that this effect could be reversedbytreatment
withIL-2 blockingantibodies,indicatingthat thisupregulation
was due to IL-2 binding. Therefore, due to their persistent
expression of fully functional IL-2Rs, following antigen
stimulation of neighboring naive Teff cells, Treg cells can
improve their capacity to scavenge IL-2 by rapidly increasing
their IL-2Ra chain densities.
As IL-2Ra chain densities on Teff cells are inﬂuenced by both
antigen concentrations and IL-2 concentrations, we measured
IL-2Ra levels on antigen-activated Teff cells in the presence or
absence of Treg cells (Figure 3E). The presence of Treg cells
resulted in a reduction of IL-2Ra levels on Teff cells activated at
low-antigen concentrations, but not at saturating antigen
concentrations (Figure 4B). This decreased expression of IL-
2Ra in weakly activated cells can only be partially reversed by
a saturating concentration of IL-2, suggesting that additional
Treg suppressive mechanisms, besides IL-2 consumption, may
beactinginparalleltoalterIL-2Ralevels(vonBoehmer,2005).
As shown previously (Figure 2), Teff cells with higher IL-2Ra
levels can sense lower concentrations of IL-2 and should thus
be less sensitive to IL-2 scavenging by Treg cells. On the other
hand, higher IL-2Ra levels on Treg cells make these better IL-2
scavengers. Thus, by comparing IL-2Ra levels on cocultured
Treg and Teff cells, we uncovered a critical crossover between
the IL-2Ra levels on the Teff- and Treg-cell populations: at low-
peptide concentrations, Treg cells have higher IL-2Ra levels
than activated Teff cells, but this is reversed at high peptide
concentrations (Figure 4C). This implies great plasticity in the
ability of Teff versus Treg cells to take advantage of the shared
pool of secreted IL-2.
Computer model: Treg can inﬂict a ‘double hit’
on Teff cells by depleting the available IL-2 and
reducing their IL-2Ra levels
To test the signiﬁcance of this dynamic competition for IL-2
between Teff and Treg cells and capture the dynamics of each of
their respective IL-2/IL-2R signaling pathways, we built a
computational model (see Materials and methods). This
model incorporates our measurement of IL-2 signaling at the
single-cell level (Figure 2), our measurement of IL-2 depletion
(Figure 3), and negative- and positive-feedback loops for IL-2
production and receptor levels, respectively (Figure 4; Supple-
mentary information 1). The negative regulation of IL-2 by
pSTAT5 causes IL-2 secretionand accumulation to be transient
and constitutes a majordifference between our model and that
presented in Busse et al (2010) in which IL-2 secretion is
bistable due to positive feedback with pSTAT5. A more
complete model including spatial resolution and accounting
for IL-2 diffusion in the extracellular medium yields compar-
able results (see Supplementary information 8). Note that,
given our experimental settings, we are able to model our
system in a well-mixed manner. This assumption was
validated experimentally by comparing the pSTAT5 response
of T cells in our experimental settings, to the same pSTAT5
response when the same T cells have been stripped of their
bound IL-2 and re-exposed to their original supernatant after
mixing (Supplementary information 9). We found that these
two pSTAT5 responses were similar thus validating our well-
mixed approximation in our model.
We simulated the ﬁrst 60h of T-cell activation for different
cell densities as well as for different rates of IL-2 production
and IL-2Ra expression(Kemp et al, 2007), both in the presence
or absence of Treg cells. Given the experimentally measured
parameters included in the simulation, we found that Treg cells
can indeed deplete IL-2 and limit IL-2Ra upregulation thereby
inﬂictinga‘double hit’onweaklyactivatedTeffcellsthat stiﬂes
pSTAT5 response (Figure 5A and B). The model predicted that
strongly activated Teff cells will manage to express IL-2Ra at
higher levels than the Treg cells, thereby maintaining high
phosphorylation of STAT5 despite enhanced IL-2 depletion by
Figure 4 Variable IL-2Ra upregulation in cocultures of Treg and Teff cells after 24h of antigen activation. (A) Non-TCR-activated Treg cells upregulate IL-2Ra when
cocultured with antigen-activated Teff cells. Reversal of this effect by IL-2 blocking antibodies shows that this IL-2Ra upregulation is speciﬁcally triggered by the IL-2
secreted by neighboring Teff cells. (B) The presence of Treg cells decreases IL-2Ra levels for weakly (1nM, left panel) but not strongly (1mM, right panel) stimulated Teff
cells. This effect is only partially reversible by addition of exogenous IL-2. (C) IL-2Ra levels (of 200 representative cells) and their geometrical mean on peptide-
stimulated Teff and non-TCR-activated Treg cells cocultured with different antigen doses. For the effector cells, the geometrical mean is taken over the IL-2Ra
þ
population only.
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strongly activated Teff cells remains minimal, and Teff cells are
able to proliferate in response to even low IL-2 concentrations.
To make further progress we tested numerically how
different densities of Teff cells (under weak or strong antigen
stimulation) are affected by the presence of an equal number
of Treg cells (Figure 5E). For strong stimulation, we found a
‘quorum-sensing’ threshold (Surette et al, 1999; Burroughs
et al, 2006), as a minimal number of cells is necessary to
secrete enough IL-2 leading to sustained pSTAT5 levels. This
threshold is not affected by the addition of Treg cells. For
weaker activation, the minimal density of cells that sustain
pSTAT5 increases because of diminished IL-2 secretion and
diminished expression of IL-2Ra. For these weakly activated
Teff cells, the addition of Treg cells completely inhibits the
simulated pSTAT5 response (Figure 5E). Hence, our model has
unraveled the intricate cell-density-dependent dynamics of
IL-2 regulation that explains the plasticity of Teff/Treg competition.
In vitro validation of computer model predictions
Next, we went on to test the key prediction from our model:
whether this IL-2 depletion by Treg cells indeed acts as a core
mechanismtosuppressdifferentiallyalargenumberofweakly
activated cells but not strongly activated ones, even in small
numbers (Sakaguchi et al, 2009). We cultured 5C.C7TCR-trans-
genic T cells with Treg-depleted B10.A splenocytes and a low
concentration of antigenic peptide. We found that little IL-2
accumulated in the medium and little pSTAT5 was generated
at low cell densities (o10cells/ml) (Figure 6A). However,
increasing the density to 4100cells/ml led to higher concen-
trationsofsecretedIL-2, thereby increasing thefractionofcells
phosphorylating STAT5. This clearly demonstrates that auto-
crinesignaling(wherebyeachcellrespondstoitsownsecreted
cytokine) is negligible in our experimental settings, while it is
the paracrine loop (whereby cells contribute a shared secreted
IL-2) that drives STAT5 response (see Supplementary informa-
tion 9 for further discussion). As predicted by our simulations
(Figure 5E), this ‘quorum-sensing’ mechanism could enable
the expansion of weakly activated cells when cultured at a
sufﬁcient density. Our model predicted that this expansion
should be actively disrupted by the presence of Treg cells.
Accordingly, we tested how Treg cells affect phospho-STAT5
levels in Teff cells depending on activation conditions. We
measured a marked decrease in IL-2 concentrations when Teff
cells were cocultured with complete splenocytes compared
Figure 5 ComputersimulationsoftheIL-2tug-of-warbetweenTeff andTregcells.(A–D)Wemo de le dinsilicotheﬁrst60h ofactivationofacultureofTeff cells (7 strongly
activatedor70weaklyactivatedcellsperml)inthepresenceorabsenceof70Tregcellsperml.WeplotthesimulatednumbersofIL-2RaandpSTAT5/cell,andthesimulated
IL-2 concentration(infMol)inthe medium.Wepresenttwoextreme cases illustratinghow Treg cells cansuppress pSTAT5inweaklyactivatedcells atahighdensity(arrow,
panelB),whilemarginallyaffectingpSTAT5forstronglyactivatedcellsinasmallerdensity(arrow,panelD).Wechosetheseconditionssuchthat,intheabsenceofTregcells,
theIL-2levelssecretedinbothcaseswerematched(panelsAandC);themajordifferencebetweenthesetwocasesisthenthemaximalIL-2Ralevelsthatthecellspresent
ontheirsurfaceuponactivation.NotethatsimulatingthesystemwithaheterogeneouspopulationofTcellswasfoundnottoaffectmodelingpredictionsforourexperimental
setting(ourunpublisheddata).Hence,inourpresentmodel,all Teff cells sharethe sameactivationstrength,andall Tregcells sharethesamelevel ofIL-2Ra.( E)Co mp ut er
predictionofadifferentialeffectofTregcellsonthequorum-sensingthresholdforSTAT5phosphorylationofstronglyactivatedversusweaklyactivatedTeffcells.Wecompute
the total pSTAT5 (in molecules/cell) generated after 60h in individual Teff cells, simulated at varied density with or without an equal density of Treg cells.
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our model predictions presented in Figure 5: Treg cells induce a
marked decrease in STAT5 phosphorylation in Teff cells, by
limiting IL-2Ra upregulation and depleting IL-2 (Supplemen-
tary information 10–12). This double hit suppressed weakly
activated Teff cells even at high density, but not strongly
activated Teff cells at lower density, both in terms of STAT5
phosphorylation (Figure 6C–F) and proliferative capacity
(Figure 6G–I). This suppressive effect is enhanced if IL-2Ra
levels on Treg cells are upregulated by pre-exposure to IL-2
in vitro (Supplementary information 13) again consistently
with our model predictions. Note that IL-2 is dramatically
lowered and pSTAT5 is slightly decreased in Teff cells in the
presence of Treg cells for strongly activated cells, Figure 6B and
E. This is consistent with our model (Figure 5B, D, and E): at
high-cell density, in the presence of Treg cells, cells consume
IL-2 so efﬁciently they may reduce slightly the amount of
phosphorylated STAT5 per strongly activated Teff cell
(Figure 6E); this decrease was predicted by our model
(Figure 5C and D). To conclude, our in vitro measurements
Figure 6 Treg cells inﬂict an IL-2Ra /IL-2 double hit to differentially suppress a large number of weakly activated but not a small number of strongly activated effector
cellsinvitro.(A)pSTAT5responsefor5C.C7Tcellsat46hofstimulationwith0.3mMK5(theredlineisasimpledose-responseﬁtandaguidetotheeyes).Althoughall
cells were stimulated by the same antigen dose, only those at high densities sense IL-2 and phosphorylate STAT5. At low densities, cells do not sense IL-2 at all, ruling
out the possibility of an autocrine loop. (B) IL-2 concentrations are similar for many weakly or a few strongly activated cells (60000 cells with 2nM of K5 peptide versus
3000 cells with 100nM K5). When we added 60000 Treg cells (yielding a ratio of Teff:Treg cells of 1:1 or 1:20), we found a similar scavenging effect for IL-2. (C–F)
Comparing pSTAT5 levels in effector cells in the presence or absence of Treg cells at 37h (C–D) or at 61h (E–F) reveals a marked speciﬁc suppression of weakly
activated effector cells only (D, F). (G, H) Suppression of proliferation, as measured by CFSE dilution at 61h, is more pronounced for many weakly activated effector
cells (H) than for a few strongly activated cells (G). (I)T reg cells suppress the proliferation of Teff cells better for cells undergoing weak antigen activation ([K5]¼0.3nmol)
compared to cells undergoing strong antigen activation ([K5]¼200nmol). The suppression index is deﬁned as the ratio of the numbers of Teff cells undergoing
proliferation in the presence of Treg cells with the numbers of Teff cells undergoing proliferation in the absence of Treg cells after peptide stimulation. These data were
pooled from four separate experiments.
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dynamic regulation of IL-2 competition.
Pre-exposure to IL-2 limits the proliferation of
Teff cells in vivo
Finally, we tested whether our theoretical model and in vitro
results provided key insights and predictions for an in vivo
model of T-cell proliferation (Figure 7A). We used adoptive
transfer of CFSE-labeled TCR-transgenic Tcells and immuniza-
tion with agonist peptide to quantify the proliferation of these
cellswith or without additional exposure to IL-2. Similar to the
invitroobservation described above(Figure 3C), Tregcellsalso
upregulate IL-2Ra (CD25) levels in response to IL-2 exposure
in vivo. We compared IL-2Ra levels in the spleen of naive mice
treated with four intra-peritoneal injections of 1.5mg human
IL-2 during 24h, with control mice injected with carrier PBS.
While we found no signiﬁcant differences in cell numbers, or
frequencies of CD4
þ or CD4
þFoxP3
þ Treg cells (see Supple-
mentary information 14), we report here a marked increase
(by three-fold) in IL-2Ra levels accompanied by an increase in
IL-2Rb levels on Foxp3
þ cells in IL-2-treated mice (Figure 7B;
Supplementary information 14). This is consistent with the
fact that, in naive mice, normally only Treg cells constitutively
express IL-2Ra, and thereby are capable of forming a high-
afﬁnity trimeric IL-2r that can signal.
In a subsequent experiment, we adoptively transferred 1
million CFSE-labeled 5C.C7 TCR-transgenic Rag2
 /  lympho-
cytesincongenicrecipients.Wetheninjectedintraperitoneally
four doses of 1.5mg of IL-2 or PBS carrier within 24h
(Figure 7A). Twelve hours after the last injection, we
immunized these mice with 10mg of MCC-102S peptide and
10ng of LPS. Thirty-six hours post-immunization, we
harvested the spleens, and analyzed the proliferation of
5C.C7 cells (Figure 7C). We found that mice that were pre-
exposed to IL-2 (and had upregulated the IL-2Ra levels in their
Figure 7 Early administration of IL-2 has a suppressive effect on Teff cell proliferation upon peptide immunization in vivo.( A) Experimental protocol (asterisks indicate
additional i.p. injection of 1.5mg of rhIL-2 for the control experiment presented in Figure 7D). (B) CD4
þFoxp3
þ Treg cells, but not CD4
þFoxp3
  Teff cells, respond to
four in vivo injections of 1.5mg rhIL-2, over 36h before immunization, by upregulating IL-2Ra levels (PBS is used as a negative control). (C) CFSE dilution in Teff cells
36h after immunization. (D) IL-2-treated and PBS-treated (control) mice before immunization reveal a signiﬁcant negative effect of early IL-2 administration on the
percentagesofcellsthatstartdividingfollowingimmunization(k).However,IL-2treatmentpost-immunizationcompensatesforthisdefectiveproliferation(markedwith*
in Figure 7A and with m in this panel).
IL-2 tug-of-war between effector and regulatory Tcells
O Feinerman et al
& 2010 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2010 9Treg cells; Figure 7B), created an environment that limited Teff
cellproliferation.Thenumberofcellsthatstartedtoproliferate
after 36h of exposure to the antigen was reduced by half if the
mice had been pre-exposed to IL-2 (Figure 7D).
To rule out possible effect of IL-2 pre-exposure that would
not be Treg mediated, we veriﬁed that CD4
  splenocytes
fraction from either IL-2 or PBS pre-treated B10.A mice can
comparatively stimulate 5C.C7 cells, in vitro (Supplementary
information 15). Furthermore, we used an adoptive transfer
strategy to rule out possible off-target effects on the host
environment. As described in Supplementary information 16,
Treg cells were isolated from mice that were injected with IL-2
or PBS and adoptively transferred along with 5C.C7 spleno-
cytes into CD3e
 /  mice on which immunizations were
performed:suppressionofTeffcellproliferationinthepresence
of IL-2 pre-exposed Treg cells (see Supplementary information
13) is consistent with the results in Figure 7C. We went on to
conﬁrm that IL-2 is indeed the limiting factor during Teff
proliferation when Treg cells have upregulated IL-2Ra: further
injections of IL-2 were performed after immunization and
abrogated the suppression observed when mice were pre-
exposed to IL-2 (Figure 7D). These in vivo results concur with
predictions derived from our in vitro and in silico models: IL-2
leadstoupregulationofIL-2RainTregcells,thatcorrelateswith
their enhanced suppressive capacity for Teff proliferation.
Discussion
In this paper, we have analyzed quantitatively how IL-2
critically regulates immune responses and enforces ligand
discrimination at the systems level. In particular, we quantita-
tively analyzed how the competition for IL-2 shapes the
proliferative response of a population of Teff cells when Treg
cells are present. Both Teff and Treg cells rely on IL-2 for the
upregulation of their surface IL-2Ra (Figure 3), such that the
binding of this shared cytokine to one of these cell types often
comes at the expense of the other. Consequently, one must
account for potential plasticity in the competition for IL-2. Treg
cells express IL-2Ra constitutively, and are the ﬁrst cells to
bind (O’Gorman et al, 2009) and degrade IL-2 produced by
neighboringTeff cellsuponstimulation (Figure3F).Thisdrives
IL-2Ra upregulation on Treg cells, accelerating their capacity to
scavengeIL-2(Figure3D).AsTeffcellsaredependentonIL-2to
survive and proliferate, this cytokine depletion can severely
impede their clonal expansion. On the other hand, upon
binding IL-2, Teff cells also upregulate IL-2Ra, thereby
increasing their afﬁnity for IL-2, and consequently, their
resistance to its depletion (Figure 2). Hence, there exists a tug-
of-war for IL-2 between Teff and Treg cells controlling the
decision between proliferation or the lack thereof (Sakaguchi
et al, 2009).
Recently, Busse et al presented a model for such IL-2
competition between Teff and Treg cells, and emphasized, in
particular, that the expression of IL-2Ra in Teff cells is all-or-
none after 72h of activation in vitro. This contribution
addressed how Treg cells could suppress Teff cells at a distance,
via competition for IL-2, see Figure 5 in Busse et al (2010). This
isparticularlysigniﬁcantasthelackofsuppressionforTeffcells
when Treg cells are separated by a ﬁlter membrane (so-called
transwell assay) has frequently been misinterpreted as a need
for cell–cell contact in Treg suppression (Thornton and
Shevach, 1998). Indeed, in transwell assays, cytokine com-
munication (e.g. IL-2 competition) is delayed by diffusion in a
way that may generate false-negative results (Pandiyan et al,
2007; Shevach, 2009) (our unpublished data). Busse et al’s
contribution demonstrates how competition for IL-2 without
cell–cell contact may be sufﬁcient for Treg suppression.
However, our experimental results and current knowledge
drawn from the literature challenge some of the premises for
Busse et al’s model, and justify the need for an alternative
model like the one introduced here.
First,Busseetal’smodeliscriticallydependentonautocrine
loops in cytokine regulation of Teff cells. Yet the relevance of
autocrine loops for IL-2 in these cells can be ruled out
experimentally. For example, upon diluting a population of
activated Tcells to low densities (o100cells/ml), we could not
detect any phosphorylation of STAT5 while some of the cells
were producing IL-2 (as measured with a cytokine capture
assay); separately, we checked that these cells could respond
to a high dose of IL-2 (our unpublished data). Hence, IL-2 can
feedback on T-cell activation via a paracrine loop but not an
autocrine loop. Similar observations have been previously
reported in an in vivo model of infection (Long and Adler,
2006). Thus, any model of IL-2 regulation cannot rely on
autocrine regulation of this cytokine to understand Teff/Treg
competition.
Busseetal’smodelalsofunctionswithlowexpressionlevels
of IL-2 receptors (e.g. 6000 IL-2Ra/cell), such that it takes
460pMol of accumulated IL-2 to get any IL-2 responsiveness
in Teff cells. Our single-cell measurements highlight how
varied and signiﬁcant IL-2Ra levels can be in Teff cells (from 0
to 3 10
5 copies; see Supplementary information 2E), with
responsiveness down to 100fMol (Figure 2E). A linear
relationship between bound IL-2 and IL-2Ra levels was
uncovered previously (Supplementary information 1 of Busse
etal),butthisis insufﬁcienttopredictSTAT5phosphorylation,
asthecomplete tetrameric assemblyofthe IL-2/IL-2R complex
is required for signaling (Figure 2G).
There exist further discrepancies in the experimental
observations that stress the incompatibilities of our model.
Busse et al report digital regulation of IL-2Ra, but this is
accurate only after 72h of culture in vitro, when cells undergo
proliferation. At shorter time scales (o60h), we found that IL-
2Ra levels are in fact extremely varied (Figures 2A, 3, and 4).
Busse et al’s model predicted that IL-2 could not accumulate
away from the cells, because of autocrine capture: our
experimental measurements report bulk levels of IL-2 as large
as 100pMol at earlier time, 24h post-activation (Figure 6B).
We also checked that there is no heterogeneity in IL-2
response, by comparing pSTAT5 response in our cell cultures,
to their pSTAT5 response in well-mixed conditions (Supple-
mentary information 9).
Finally, Busse et al’s model comprises a positive feedback
loop for the production of IL-2 by Teff cells, upon sensing IL-2.
This positive feedback appears to drive the digital proﬁle in
IL-2Ra levels, and maintains high concentrations of IL-2 after
10h of simulated time and at later time points, cf Figure 2C in
Busse et al (2010). However, our measurements on IL-2
concentrations in culturesof Teff and Tregcells showthat IL-2 is
IL-2 tug-of-war between effector and regulatory Tcells
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IL-2 is transient (Figure 6B; Supplementary information 9B).
Ourresultsareconsistentwith thestrongnegativefeedbackon
IL-2 production reported by others (Kim et al, 2006; Villarino
et al, 2007), and the transient nature of IL-2 accumulation
(Sojka et al, 2004).
Owing to these observations, we posit that Busse et al’s
modeloperateswithanIL-2feedbackandanoverallparameter
regime that are incompatible with our new experimental
results. Hence, the quantitative mechanism for immune
regulation derived previously (Busse et al, 2010) could not
be validated in vitro. Our new measurements (Figures 2–5)
allowed us to introduce an alternative quantitative model for
IL-2 regulation, based on differential signaling through IL-2R,
and dynamic feedback regulation for Teff and Treg cells. Our
model ﬁrmly establishes the quantitative role of the competi-
tion for IL-2 to shape the balance between immune tolerance
and immune response (Figure 8). Of note, the validity and
functional relevance of our quantitative model was tested with
quantitative predictions from our model that we validated
experimentally in vivo (Figure 7).
By developing a new computational model to account for
this dynamic competition for IL-2 between T cells, we were
able to predict and subsequently validate experimentally that
Treg cells can suppress large densities of weakly activated Teff
cells while strongly activated Teff cells, due to their high
expression levels of IL-2Ra, are unaffected by the presence of
Treg cells (Figure 8). Hence, our theoretical framework
provides a mechanistic explanation for the large plasticity of
suppression of Teff cells by Treg cells (Sojka et al, 2005;
Stephens et al, 2005; Tran et al, 2009). Other mechanisms of
suppression (e.g. the roleof CTLA-4 or the competition for IL-6
in Th17/Treg balance) will need to be considered to estimate
their quantitative relevance to Treg function.
Our study also emphasizes howcritical it is to combine both
theoretical modeling and experimental measurement of T-cell
function at the level of individual cells instead of simply
monitoring a population average. At a given IL-2 concentra-
tion, only a fraction of cells, as determined by their IL-2Ra
levels, will receive a survival signal or scavenge the cytokine.
Thus,theplasticregulationofIL-2amongTcellscanbeviewed
as a means to maintain a ﬂexible balance at the population
level that leads either to the onset or to the suppression of
immune responses. Subtle disruptions in this balance, either
because of genetic defects (Vella et al, 2005; Brand et al, 2007;
Yamanouchi et al, 2007) or by direct application of IL-2
(Brandenburg et al, 2008; Tang et al, 2008), have been shown
to strongly affect the inception of autoimmune disorders with
potential therapeutic implications. For example, a controlled
regimenofIL-2injection couldrestoretheTreg/Teffbalanceand
block the onset of diabetes in NOD mice (Tang et al, 2008). In
another study, Webster et al (2009) injected IL-2/antibody
complexes in mice for 3 days,and recordeda robust expansion
of the Treg pool and enhanced tolerance and resistance to EAE
or diabetes. Our system is more contained: we tested effects of
IL-2 injection (without crosslinking/activating S4B6 antibody)
on o3-day short time scales (Figure 7). In particular, we did
not record anyenlargement of the Treg pool in the IL-2-injected
mice (Supplementary information 14). But our computational
model (Figure 5) also highlights how higher levels of IL-2Ra in
an expanding Treg cell pool could account for their enhanced
suppressive capacity in the experiments by Webster et al
(2009) (see their Figures 1D and 2C) as well as in the
experiments by Tang et al (2008) (see their Figure 4A), and
others’(Pandiyanetal,2007).Moregenerally,ourquantitative
understanding of the IL-2 competition between Treg and Teff
cells opens new avenues to manipulate the balance between
immune tolerance and immune responsiveness (Figure 7).
Additional mechanisms of suppression, e.g. IL-10 secretion,
CTLA-4 upregulation, etc. (von Boehmer, 2005), will need to
beaddedtoourmodeltoreﬁneourquantitativeunderstanding
of the function of Treg cells. Moreover, spatial considerations,
Figure 8 Sketch of the differential suppression by Treg cells, based on the ‘double hit’ cytokine depletion mechanism. Empty green circles denote Teff cells and full red
circlesdenoteTregcells.IncreasedfontsizeforIL-2RaandIL-2isusedtosignifyincreasedlevelsforthesereceptorandcytokine.ThissketchsummarizeshowTregcells
can suppress pSTAT5 and proliferation signals in large numbers of weakly activated Teff cells, while allowing a small number of strongly activated Teff cells to maintain
pSTAT5 and proliferate.
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function in regulating the IL-2 competition between Treg and
Teff cells: futurework will include the diffusion of this cytokine
in more realistic conﬁned geometry, in addition to the
signaling feedback regulation quantiﬁed in the model pre-
sented here.
To conclude, by combining single-cell measurement and
quantitative modeling of pSTAT5 responses in Tcells, we have
established quantitative rules for the IL-2 tug-of-war between
Tregand Teff cells.Timing, molecularcell surface densities,free
molecular concentrations, and competition for cytokine
secretion and sensing are critical characteristics of immune
responses that classical genetic approaches cannot quantify
(Tomlin and Axelrod, 2007; Schulz et al, 2009). Particularly,
our study demonstrates for the ﬁrst time how qualitative
functional consequences of weak versus strong antigenic
recognition leads to exquisitely sensitive feedback regulation
of the IL-2/IL-2R signaling system and enforces self-/non-self-
discrimination at the system level. We anticipate that such
quantitative modeling combined with experimental single-cell
resolution of molecular expression will be an increasingly
useful method to dissect how cytokine regulation and
competition dynamically shape cellular responses in the
immune system.
Materials and methods
Mice
Breeding pairs of 5C.C7 TCR-transgenic Rag2
 /  (Seder et al, 1992),
B10A CD3e
 /  and B10.A mice were obtained from Taconic (Hudson,
NY). These mice were bred, and maintained in the animal facilities of
the Memorial Sloan-Kettering Cancer Center (MSKCC) according to
our institutional guidelines. All experiments were performed with
mice of age between 1 and 3 months.
Media
All in vitro experiments were performed in complemented RPMI
medium, prepared by the Media facility at MSKCC. It consists of RPMI
1640 supplemented with 10% heat-inactivated fetal bovine serum,
2mM L-glutamine, 10mM HEPES (pH 7.4), 0.1mM non-essential
amino acids, 1mM sodium pyruvate, 100mg/ml of penicillin, and
100 mg/ml of streptomycin and 50mMo fb-mercaptoethanol. All cell
cultures were maintained in an incubator at 371C with 5% CO2.
Reagents and antibodies
RecombinantmethionylhumanIL-2(hIL-2)wasobtainedfromAmgen
(Thousand Oaks, CA). Recombinant mouse IL-2 (mIL-2) was obtained
from eBioscience, CA. The following antibodies were used: anti-
CD3(2C11), anti-CD4 (RM4–5) (APC-Cy7), anti-IL-2Ra (anti-CD25,
PC61) (PE-Cy7), anti-IL-2Ra (anti-CD25, 7D4) (biotin), anti-
CD28(35.51), anti-IL-2Rb (anti-CD122, Tm.b1) (biotin or PE) were
from BD Bioscience (San Jose, CA); anti-phospho-STAT5(Tyr 694) was
from Cell Signaling; anti-Rabbit IgG (APC) from Jackson ImmunoR-
esearch (West Grove, PA); Mouse non-lytic IL-2/Fc fusion protein was
from Chimerigen (Allston, MA). DAPI and CFSE dyes were obtained
from Fluka/Sigma/Aldrich (St Louis, MO).
All staining were performed in FACS buffer (PBS with 4% fetal calf
serum (FCS) and 0.1% sodium azide). All ﬂow cytometer acquisitions
were performed on a LSR-II machine (Beckton-Dickinson, San Jose,
CA). Special care was taken to set up the compensation matrix with
single-stained samples before each acquisition.
Cell preparation
CD4
þCD25
þ cells were puriﬁed from a cell suspension harvested
from B10.Aspleenandlympnodes, usinga MACSTreg-cellisolationkit
(Miltenyi Biotec, Auburn, CA) according to the manufacturer’s
instructions. In other experiments, CD25
þ cells were depleted using
a MACS CD25 microbead kit (Miltenyi Biotec). 5C.C7 T cells were
collected from the spleen and lymph nodes of the 5C.C7 TCR-
transgenic Rag2
 /  mouse.
CFSE labeling
5C.C7 splenocytes were labeled with 2mM CFSE for 10min at 371C.
Excess unreacted CFSE was removed with two cold washed with
RPMI. Cells were placed in culture in vitro, or washed in PBS and
adoptively transferred immediately after labeling.
Measuring pSTAT5 response to varying IL-2
concentrations
We used 5C.C7 Tcells that were cultured for 48–72h in the presence of
irradiated APCs (from B10A spleens) and 100nM K5. This cell culture
maximizes the heterogeneity in IL-2Ra expression. Cells were then
collected and dead cells removed by centrifugation on a ﬁcoll gradient
(GE,Uppsala,Sweden).Bound IL-2 wasstrippedfromcell surfacebya
2-min incubation with 0.1M Glycine buffer equilibrated at pH 4.0,
followed by a 5-min wash in RPMI (Duprez et al, 1988). Cells were
then aliquoted and exposed to different concentrations of IL-2 for
10min in 371C.
Single-cell staining
Following protocols optimized by the Nolan group (Krutzik et al,
2005). Cells were ﬁxed by 15min incubation in 1.6% paraformalde-
hyde in PBS. In experiments where cells were stained directly after
culture ﬁxation was stopped after 10min, followed by surface staining
with biotinilated anti-IL-2Ra antibody, followed by 5 extra minutes in
1.6% PFA. After spinning down the cells, they were resuspended in
90% MeOH on ice (or at  201C for overnight storage). Cells were then
washed twice in staining buffer and stained intracellularly for pSTAT5
or rIgG Isotype control and different combinations of CD4, IL-2Ra, IL-
2Rb, and streptavidin (for surface IL-2Ra).
To measure the correlation between IL-2 binding and STAT5
phosphorylation, we used T-cell blasts that were stripped of surface
IL-2 (see above; Duprez et al, 1988). Cells were then exposed to
100pmolIL-2-Fc fusion protein and incubated for 60min at 371C. Cells
were then washed, ﬁxed with ice-cold 1.6% paraformaldehyde for
10min, and permeabilized with ice-cold methanol (90% in water) for
10min.Cellswere thenwashedtwicewithFACSbuffer,andstainedfor
pSTAT5 (primary staining) then anti-rabbit(PE)þanti-mouse(APC)þ
anti-IL-2Ra(PECy7).
IL-2 depletion
B10.A mice were administered intraperitoneally with four doses of
either 1.5mg of hIL-2 or PBS during a period of 24h. The spleen and
lymphnodesofthemicewereharvestedabout10h afterﬁnalinjection
and CD4
þ cells were isolated by negative selection with a cocktail of
antibodies (against CD8a
þ, Ter119
þ, CD11b
þ, CD45r
þ, and
CD49b
þ) using the miltenyi magnetic bead kit. Cells were counted
before experiment to ensure a known number of CD4
þCD25
þ cells.
Cells were then placed into 96-well plates, 150ml per condition in the
presence of a known amount of mIL-2. Supernatants were collected at
differenttimepointsforanalysisbyELISA,insomeofthesetimes,cells
were restained for IL-2Ra and IL-2Rb levels to track the changes in
their expression over time.
Biochemical model for STAT5 signaling and IL-2
depletion
We developed a biochemical model to simulate the binding of soluble
IL-2 onto a heterogeneous population of cells expressing varied levels
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trimeric complex IL-2RaKIL-2RbKIL-2Rg). The cell population was
binned into N groups depending on their receptor levels, each group
(indexed by i) may hold an arbitrary number of cells which are
considered identical. This model expands the ligand/receptor interac-
tion section speciﬁed in Table I to N bins and consists of 4 Nþ1r a t e
equations:
d
dt
½IL-2Ra i ¼  k1ðonÞ½IL-2Ra i ½IL-2 þk1ðoffÞ½IL-2Ra   IL-2 i;
d
dt
½IL-2   IL-2Ra i ¼ k1ðonÞ½IL-2Ra i
 ½IL-2  k1ðoffÞ½IL-2   IL-2Ra i
  k2ðonÞ½IL-2   IL-2Ra i ½IL-2Rb=IL-2Rg 
þ k2ðoffÞ½IL-2   IL-2R i;
d
dt
½IL-2Rb=IL-2Rg i ¼  k2ðonÞ½IL-2   IL-2Ra i
 ½IL-2Rb=IL-2Rg þk2ðoffÞ½IL-2   IL-2R i;
d
dt
½IL-2   IL-2R i ¼þ k2ðonÞ½IL-2   IL-2Ra i
 ½IL-2Rb=IL-2Rg  k2ðoffÞ½IL-2   IL-2R i;
d
dt
½IL-2 ¼  k1ðonÞ
X N
i¼1
½IL-2Ra i ½IL-2 
þ k1ðoffÞ
X N
i¼1
½IL-2   IL-2Ra i;
where k1(on)¼1.4 10
7/mol/s, k1(off)¼0.4/s, and k2(off)¼2.3 10
 4/s
were previously directly measured (Wang and Smith, 1987). As a
simpliﬁcation that had no inﬂuence on model results (see Supple-
mentaryinformation6),IL-2RbbindingandIL-2RgbindingtoIL-2KIL-
2Ra complex were considered as a single-dynamical step (rather than
two subsequent steps); the symbol IL-2Rb/IL-2Rg should be taken to
signify this fact and does not imply a pre-formed complex. In these
equations, the brackets [ ] designate bulk concentration in pM which
was calculated for surface receptors, by multiplying the number of
receptors/cell by the total number of cells in the bin and dividing
by Na Avogadro’s number and the total volume. k2(on) was ﬁt as
described in the main text. The actual value for each bin is
k2(on)¼3.3 10
 4 10
 12 Na  (DensityofCell)
 1, where Densityof-
Cellisthenumberofcellsinbindividedbythetotalvolume.Thissetof
differential equations were solved using MATLAB software and
simulated deterministically for a period of 10min that is shorter than
the half-life of the IL-2KIL-2r complex so that receptor internalization
could be neglected (Duprez et al, 1991).
WecheckedthatthemapofSTAT5phosphorylationforvariedlevels
of IL-2Ra was identical for Treg and Teff cells (Supplementary
information 5), hence we used the same equations and parameters
(ligand and receptor section of Table I) to model types of T cells. To
estimate IL-2 depletion for extended period of times, the 10-min
simulation was iterated many times when the ﬁnal IL-2 concentration
of one run is used as the initial concentration of the next. The half-
lifetime of the full complex before depleted by 15min, while the
other half stays bound to the cells’ surface as a starting condition for
the following iteration. In these ﬁts, all cells were assumed to have a
Table I List of parameters for biochemical model
Reaction On rate Off rate
Ligand receptor interaction
IL-2+IL-2Ra2IL-2KIL-2Ra 1.4 10
7/mol/s 0.4/s
IL-2KIL-2Ra+IL-2Rb/IL-2Rg 2
IL-2KIL-2RaKIL-2RbKIL-2Rg
3 10
 4/s 2.3 10
 4/s
Reaction On rate Off rate
Signaling and regulation
IL-2Ra-+ 5 10
 5/s
IL-2Rb/IL-2Rg-+ 5 10
 4/s
IL-2KIL-2RaKIL-2RbKIL-2Rg - + 1.1 10
 3/s
IL-2KIL-2RaKIL-2RbKIL-2Rg+STAT5-
IL-2KIL-2RaKIL-2RbKIL-2Rg+pSTAT5
1 10
 4/s
pSTAT5-STAT5 10
 2/s
pSTAT5+PromoterIL-2Ra2pSTAT5KPromoterIL-2Ra 1.2 10
 5/s 2 10
2/s
pSTAT5+PromoterIL-2Rb/IL-2Rg2
pSTAT5KPromoterIL-2Rb/IL-2Rg
1.2 10
 4/s 2 10
2/s
pSTAT5+PromoterIL-2 -pSTAT5KPromoterIL-2 1.2 10
 7/s
Protein (inducer) Expression rate
Expression levels
IL-2Ra transcription (TCR induced) 0.4/s (Treg); 0.25/s (Teff)
IL-2Ra transcription
(TCR+pSTAT5 induced)
2.7/s (Treg); 2.8/s (Teff)
IL-2Rb/IL-2Rg transcription (TCR induced) 0.1/s (Treg,T eff)
IL-2Rb/IL-2Rg transcription (TCR+pSTAT5 induced) 0.2/s (Treg,T eff)
IL-2 transcription (TCR induced) 0 (Treg), 0.7/s (Teff)
IL-2 transcription (TCR+pSTAT5 induced) 0 (Treg), 0.18/s (strong Teff)
Molecule Copies/cell
Initial values
IL-2Ra 10
4 (Treg)0( T eff)
IL-2Rb/IL-2Rg 3 10
2
STAT5 2 10
3
PromoterIL-2Ra 2
PromoterIL-2Rb/IL-2Rg 2
PromoterIL-2 2
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change over long periods of time. Rather than simulating them,
these levels were measured at multiple time points during the
depletion experiments and a smooth interpolation between these
measurements was used as the parameterized heterogeneity during
the simulation.
Dynamical model for the competition for IL-2
between Treg and Teff cells
A dynamical model for the regulation of IL-2Ra, IL-2Rb, and
extracellular IL-2 was simulated using BioNetGen rule based modeling
software (Blinov et al, 2004). The simulation includes the following
processes for Teff cells (as detailed in Table I):
  IL-2 binding to IL-2R. Here, we incorporate our two-step, short time
scale biochemical model of IL-2/IL-2R binding (cf Figure 2) as a
module in this longer time scale simulation. Full IL-2KIL-2R
complexes are endocytosed with a typical time scale of 15min
(Hemar et al, 1995).
  STAT5 dynamics. Including binding of STAT5 unto full IL-2KIL-2r
complexes leading to its phosphorylation and STAT5 dephosphor-
ylation.
  IL-2 dynamics. IL-2 production commences at t¼0 and scales with
TCR activation strength (Kemp et al, 2007), the maximal single-cell
secretion rate is 150 secreted molecules/min—this number is
estimated using measurements from Sojka et al (2004). Upon
endocytosis, IL-2 is degraded. IL-2 secretion downregulation as a
function of STAT5 is modeled as pSTAT5 binding to the IL-2
promoter region, irreversibly limiting further IL-2 production
(Villarino et al, 2007).
  IL-2Ra dynamics. IL-2Ra upregulation commences at t¼0 and
scaleswithTCRactivationstrength,maximalexpressionratesareat
90molecules/cell (this was calibrated with our measurements of
the steady-state expression of IL-2Ra on Treg cells, see below).
Further IL-2Ra upregulation as a function of STAT5 phosphoryla-
tion is modeled by its increased production rate (by a factor of B6
over the TCR-induced production rate) upon reversible binding of
pSTAT5 unto the promoter region of the IL-2Ra gene. Unbound IL-
2Rareceptorsareendocytosedwithaslowtimescaleof5h(Duprez
andDautry-Varsat,1986)IL-2Rahomeostasisismaintainedbothby
recycling of endocytosed receptors (Hemar et al, 1995) and by new
synthesis of IL-2Ra.
  IL-2Rb dynamics. IL-2Rb upregulation commences at t¼0. Upon
endocytosis,IL-2Rbisdegraded(Hemaretal,1995).Further,IL-2Rb
upregulation as a function of STAT5 phosphorylation is modeled by
its increased production rate upon reversible binding of pSTAT5
untotheIL-2Rbpromoterregion.UnboundIL-2Rbsubunitsdegrade
with a typical time scale of 1h (Hemar et al, 1995).
  Initial conditions. At t¼0, Teff cells express 10
3 copies of IL-2Rb and
no IL-2Ra. The IL-2 concentration is set to 0.
For Treg cells, the same rules apply with two exceptions: Treg cells do
not secrete any IL-2 and have 10
4 copies of the IL-2Ra receptor at t¼0.
The IL-2Ra expression rate on in the absence of pSTAT5 signaling was
calibrated to be 25 units/min to maintain a steady state of 10000
receptors/cellbeforestimulation.IL-2Rbproductionratesweresetina
similar mannerand assumed to be identical between Teff and Treg cells.
O u rc o m p u t e rs i m u l a t i o ni n c l u d e sal a r g en u m b e ro fp r o c e s s e sa n d
experimentally validated parameters (see Table I); it provides valuable
dynamical insight into the competition between Treg and Teff cells.
Simulations included either one effector cell, one effector cell and one
regulatory cell or one effector cell and 10 regulatory cells (Figure 5D). We
simulated these few cells in rescaled volumes to achieve varied cell
densities: that practically modeled the dynamics of varying cell numbers,
in a constant volume of 150ml as used in our experimental setup.
Weakly activated cells were modeled with production rates for IL-2
and IL-2Ra that are 10-fold lower than those in strongly activated cells.
Treg cells were modeled to have intermediate, IL-2Ra production rates:
half a decade below strongly activated cells and half a decade above
weakly activated cells. The model simulation runs under well-mixed
conditions. The simulation was run stochastically using the Gillespie
algorithm. Simulation codes will be provided upon request.
Classic suppression assay with anti-CD3/anti-
CD28 stimulation)
CFSE-stained CD4
þ Tcells from 5C.C7 TCR-transgenic Rag2
 /  mice
were cultured in U-bottom wells in 150ml of RPMI with soluble anti-
CD3 and anti-CD28 each at 0.1mg/ml. The cells were cultured either in
the presence or absence of CD4
þCD25
þ cells isolated from naive
B10.A spleens and lymph nodes using the Miltenyi isolation kit (see
reagents). Varying numbers of 5C.C7 and CD4
þCD25
þ cells were
mixed for different experiments.
Suppression assay with antigen stimulation
CFSE-stained CD4
þ Tcells from 5C.C7 TCR-transgenic Rag2
 /  mice
were cultured in ﬂat-bottom wells in 150ml of RPMI. The cells were
cocultured with either B10.A splenocytes or B10.A splenocytes
depleted of CD25
þ cells by negative selection with the Miltenyi kit.
We divided these splenocytes such that there were 50000 Treg cells/
well. Prior to culture, it was veriﬁed that the number of CD4
 CD8
  of
B10.Asplenocytesperwellismatchedbetweenthetwoconditions.For
antigenic stimulation, different concentrations of K5 (typically
between 0.1nM and 1mM) were added to the wells at t¼0. We have
veriﬁed that this suppression assay leads to a decrease in the numbers
of dividing effector cells (see Figure 6G–I).
In vivo upregulation of IL-2Ra in Treg cells upon
exposure to IL-2
B10.A mice were administered intraperitoneally with four doses of
either1.5mghIL-2(Amgen)orcarrierPBSduringaperiodof24h.Mice
were then euthanized, spleen and lymph nodes (inguinal and axillary)
were harvested, and cells were stained for surface CD4 and IL-2Ra and
intracellular FoxP3.
In vivo activation of T cells with/without pre-
exposure to IL-2
In all, 1Million 5C.C7 CD4
þ cells were stained with CFSE and
adoptively transferred into naive B10.A recipient mice. Twenty-four
hours later, these B10.A mice were intraperitoneally administered four
doses of either 1.5mg hIL-2 (Amgen) or carrier PBS during a period of
24h. Nine hours after the last IL-2 dose, the mice were immunized
intraperitoneally with 10mg of MCC-102S peptide and 0.1ng LPS. The
mice were euthanized 36h later, and the spleen was stained for CD4
and IL-2Ra. In control experiments, 1.5mg hIL-2 was administered
once with immunization then 4, 9, 22, and 29h post-immunization
prior to euthanization 36h post-immunization.
AvariantofthisassaywasperformedtoisolatetheeffectofTregcells
on cells on effector proliferation in vivo. B10.A mice were intraper-
itoneallyadministeredeither IL-2or PBS, as above. Spleensandlymph
nodes were then harvested and Treg cells isolated using a Miltenyi kit.
We then adoptively transferred, by tail-end injection, the isolated Treg
cells (that have undergone either PBS or IL-2 pre-treatment), 1Million
CFSE-labeled 5C.C7 effector cells into B10.A CD3e
 /  recipient mice.
Wecotransferred20Millionsplenocytesfromawild-typeB10.Amouse
to prevent lymphopenic expansion. Eight hours later, mice were
immunized with MCC-102S peptide and LPS, as described above.
Spleens were harvested 45h after immunization, stained for CD4 and
the Vb-3 chain of the 5C.C7 TCR and analyzed for CFSE dilution by
FACS.
Measurement of IL-2 concentrations in
supernatants by ELISA
Supernatants were collected and stored at  201C. In all, 96-well EIA/
RIA plates from Corning (NY) were pre-coated with 2mg/ml of IL-2
capturing antibody (JES6-1A12, eBioscience) in coating buffer (0.1
NaHCO3 in PBS, pH 8.2) by incubating over night at 41C. Plates were
then washed and blocked for 2h in 10% FCS in PBS. Washes with PBS
IL-2 tug-of-war between effector and regulatory Tcells
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incubated with the thawed supernatants overnight at 41C Following a
1-h incubation in 100ml/well of 1mg/ml biotinilated IL-2 detection
antibody (JES6-5H4, eBioscience) and 10% FCS in PBS. Plates were
incubated for a further hour at room temperature in 100ml/well of
1.5mg/ml alkalaine phophotase (SigmaFAST, Sigma) and 10% FCS in
PBS followed by a washes with PBS Tween and then distilled water.
Finally, wells were incubated with 100ml of PNPP tablets in a TRIS
buffer (SigmaFAST, Sigma) for about 30min in the dark and analyzed
by a Emax (Molecular Devices) plate reader for absorbance at 405nM.
Results were analyzed by MATLAB software using calibration wells
with an IL-2 titration. Error bars were estimated by computing the
standard deviation between two different sets of calibration wells.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (http://www.nature.com/msb).
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